currently recruiting
Participants for our COVID-19 Wearables Study
Learn more >
Researchers in protective gears working in a lab.

About Us

We are on a mission to fix the broken healthcare system and create equitable solutions for care.

Recognized as a global leader in precision health, Stanford Medicine is making major strides in a advancing the entire field. Dr. Michael Snyder has built the most robust precision health ecosystem in the world, with over 100 scientists working at the forefront of precision health innovation.

Stanford is ranked #1 in U.S. News 2019 for genomics, bioinformatics, biological sciences, neuroscience, and biochemistry. Our team of medical innovators lead the field at the intersection of computer science and biology. As healthcare data sources increase, we are entering a new era of precision medicine.

Researchers in protective gears working in a lab.

Lab at a Glance

  • 10,000 ft²+
    lab space
  • 100+
  • $7 billion+
    value from company spinouts

Dr. Michael Snyder

In 2009, Snyder was recruited by Stanford University to Chair the Genetics Department and to direct the Center for Genomics and Personalized Medicine. Under his leadership, U.S. News & World Report has ranked Stanford University first or tied for first in Genetics, Genomics and Bioinformatics every year since 2010. For the past decade, Mike has been using longitudinal tracking and measuring everything about human health to predict and prevent disease ahead of time. With over 100 people in his lab, Dr. Snyder is changing the landscape of diabetes, cancer, cardiovascular disease, aging, and mental health by learning how to keep people healthy rather than treat them once they are already sick.

Dr. Snyder at work.

“We are passionate about raising the standard of care for everyone. We are creating new systems that make health accessible and affordable for all.”

Michael Snyder, Ph.D.
Chairman & Professor, Department of Genetics
Director, Center for Genomics and Personalized Medicine

A Brand New Approach to Medicine

Dr. Michael Snyder has pioneered longitudinal personalized multiomic profiling, tracking and integrating millions of pieces of health data over time for an individual. This approach allows us to characterize an individual’s healthy baseline, and when deviations from baseline occur, we can intervene to maintain health. This means early detection and prevention of disease, including cancer, cardiovascular disease, diabetes, and infection.

Longitudinal + Big Data


Dr. Snyder’s laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics.


The Snyder Lab is a pioneering force in the fields of personalized health, nutrition, and precision medicine. He was the first to apply personalized health tracking on a large scale.


Dr. Snyder established the first longitudinal detailed ‘omics profiling of humans. We are measuring almost possible outcome for human health, including standard clinical tests, and nearly all of the molecules in blood, urine, stool, saliva, as well as heart rate, sleep, and airborne exposures.


Mike’s lab launches the first systems biology approach to analyzing every gene and its function simultaneously (published 1994)
Mike’s lab invents protein chips
Mike’s lab publishes first whole proteome chip;
Mike’s lab together with Pat Brown’s lab invents ChIP-Chip for widespread mapping of transcription factor binding regions
Mike lab tiles the first human chromosome and discovers widespread noncoding (lncRNAs)
Mike’s lab tiles the entire human genome for the first time and present the first generation RNA coding map of the human genome
Mike’s lab converts Chip-Chip to Chip-Seq
Mike’s lab Invents paired end sequence with nextGen technology and demonstrates widespread structural variation in the human genome;
Mike’s lab publishes first de novo genome sequencing use NexGen sequencing technology
Mike invents RNAseq the first technology to measure genetic expression (RNA) in humans
Mike launches the Stanford Center for Genomics and Personalized Medicine within Stanford
Mike invents the first Big Data Precision Health approach to medicine in his Integrated Personalized Omics Profiling protocols (published in 2012)
Mike cofounds Personalis, a genome sequencing company
Mike publishes first paper exploring how wearable devices (like Fitbit) can be used as clinical tools, including publishing the first algorithm (Change of Heart) with Xiao Li that could be used to detect infectious illnesses days before symptoms emerge
Mike’s lab demonstrates widespread glucose dysregulation using continuous glucose monitors an described Glucotype
Mike lab show big data and advances technologies can be used to manage the health of 109 people;
Mike’s spinout company Q.Bio (based on the Big Data + Longitudinal Profiling Approach) reports initial case studies detecting early stage cancers;
Mike’s lab together with others publishes first omics study of astronauts
Mike launches the Healthcare Innovation Lab to accelerate Precision Health research and development within Stanford Medicine;
Mike’s lab described personalized aging (Ageotypes)

Companies Co-Founded by Dr. Michael Snyder

Total VC Funding $242,271,345

TEAM & Affiliates

Steering Committee
Mike Snyder
Faculty Director
Benjamin Rolnik
Amir Bahmani
Science & Technology Director
Lab Member and Collaborators
Kexin Cha
UI/UX Lead
Arash Alavi
Security Lead
Ekanath Srihari Rangan
Ankit Mathur
Aubrey Roberts
Ben Slovin
Camille Berry
Eli Hong
Ghazal Mazaheri
Gregory Young
Josh Payne
Katherine Van Winkle
Lisa Liao
Mel Sampat
Mia Yang
Peter Kane
Pramod K Kotipalli
Qinyi Yao
Sarah Wilen
Meng Wang
Sushil Upadhyayula
Gabrielle Mostow
Erika Mahealani Hunting
Lettie McGuire
Peter Knowles
Francesca Goncalves
Ariel Ganz
Gireesh Bogu
Devon Bussell
Jennifer LaFreniere


The healthcare innovation lab funds highly translational work at Stanford in a non-linear fashion—allowing for high risk, high impact projects and fast iteration to bring them to clinic and market. Your gift will fund the most promising projects and allow for the creativity and flexibility that is needed to drive paradigm shifting translational research and development.

Contact Us